Vitamin K supplementation in cystic fibrosis.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 14612359.
- Also identified by PMC identifier 1719368.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The relation between different doses of vitamin K supplementation, several bone markers, and PIVKA-II concentrations in cystic fibrosis (CF) patients compared to controls was evaluated. Results suggest that a increased vitamin K intake may have significant health benefits for children with CF.
Medical subject headings
- Biomarkers
- Cystic Fibrosis
- Vitamin K